Exploiting Anti-CD3 Antibodies, Relevant Biomarkers in Progressive MS: Tanuja Chitnis, MD

Retrieved on: 2022-06-24 17:23:47

Tags for this article:

Click the tags to see associated articles and topics

Exploiting Anti-CD3 Antibodies, Relevant Biomarkers in Progressive MS: Tanuja Chitnis, MD. View article details on hiswai:

Excerpt

Nasal anti-CD3 monoclonal antibody (foralumab) reduces PET microglial activation and blood inflammatory biomarkers in a patient with non-active ...

Article found on: www.neurologylive.com